Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Abiraterone ACetate”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Early research (Phase 1)Study completedNCT01715259
What this trial is testing

A Pharmacokinetic Study of Abiraterone Acetate in Male Participants With Impaired Renal Function Compared to Individuals With Normal Renal Function

Who this might be right for
Renal Insufficiency
Cougar Biotechnology, Inc. 16
Testing effectiveness (Phase 2)Study completedNCT00544440
What this trial is testing

An Observational Study of Continuous Oral Dosing of Abiraterone Acetate in Castration-Resistant Prostate Cancer Patients Evaluating Androgens and Steroid Metabolites in Bone Marrow Plasma

Who this might be right for
Prostate Neoplasms
Janssen Research & Development, LLC 57
Large-scale testing (Phase 3)Ended earlyNCT03777982
What this trial is testing

Conventional Androgen Deprivation Therapy (ADT) With or Without Abiraterone Acetate + Prednisone and Apalutamide Following a Detectable PSA After Radiation and ADT

Who this might be right for
Prostate Cancer
Dana-Farber Cancer Institute 12
Testing effectiveness (Phase 2)Study completedNCT01381874
What this trial is testing

Abiraterone Acetate Plus Prednisone With or Without Exemestane in Postmenopausal Women With Estrogen Receptor-Positive (ER+) Metastatic Breast Cancer Progressing After Letrozole or Anastrozole Therapy

Who this might be right for
Metastatic ER+ Her2- Breast CancerPostmenopausal
Janssen Research & Development, LLC 297
Testing effectiveness (Phase 2)Active Not RecruitingNCT06212583
What this trial is testing

High-Risk Metachronous Oligometastatic Prostate Cancer Trial

Who this might be right for
Prostate CancerOligometastatic Disease
University of Maryland, Baltimore 88
Early research (Phase 1)Ended earlyNCT05295927
What this trial is testing

EPI-7386 in Combination With Abiraterone Acetate Plus Prednisone, or Apalutamide in Metastatic Castration-resistant Prostate Cancer (mCRPC)

Who this might be right for
Prostatic Neoplasms
Janssen Research & Development, LLC 3
Testing effectiveness (Phase 2)Active Not RecruitingNCT03436654
What this trial is testing

Multi-arm Multi-modality Therapy for Very High Risk Localized and Low Volume Metastatic Prostatic Adenocarcinoma

Who this might be right for
Prostate Cancer
Memorial Sloan Kettering Cancer Center 102
Early research (Phase 1)Study completedNCT04863105
What this trial is testing

Bioequivalence of Abiraterone Acetate Tablets in Healthy Chinese Volunteers

Who this might be right for
Healthy Volunteers
The Affiliated Hospital of Qingdao University 36
Testing effectiveness (Phase 2)Ended earlyNCT01717898
What this trial is testing

Phase I/II Trial of Abiraterone Acetate + BEZ235 in Metastatic, Castration-Resistant Prostate Cancer

Who this might be right for
Castrate-resistant Prostate Cancer
Charles Ryan 6
Early research (Phase 1)Ended earlyNCT01913015
What this trial is testing

Dietary Fat Levels and Abiraterone Acetate Uptake in Patients With Metastatic Hormone-Resistant Prostate Cancer

Who this might be right for
Adenocarcinoma of the ProstateHormone-resistant Prostate CancerRecurrent Prostate Cancer+1 more
OHSU Knight Cancer Institute 3
Early research (Phase 1)Study completedNCT01516047
What this trial is testing

A Pharmacokinetic Study of Abiraterone Acetate in Patients With Severe Hepatic Impairment Compared to Patients With Normal Hepatic Function

Who this might be right for
Hepatic Impairment
Janssen Research & Development, LLC 16
Testing effectiveness (Phase 2)Study completedNCT00755885
What this trial is testing

Abiraterone Acetate in Treating Postmenopausal Women With Advanced or Metastatic Breast Cancer

Who this might be right for
Breast Cancer
Cancer Research UK 77
Testing effectiveness (Phase 2)UnknownNCT01685125
What this trial is testing

Abiraterone Acetate and Prednisone With or Without Dasatinib in Treating Patients With Metastatic Hormone-Resistant Prostate Cancer

Who this might be right for
Hormone-resistant Prostate CancerRecurrent Prostate CancerStage IV Prostate Cancer
University of Southern California 96
Early research (Phase 1)Active Not RecruitingNCT04577833
What this trial is testing

Comparative Formulations of Niraparib and Abiraterone Acetate (AA) in Men With Prostate Cancer

Who this might be right for
Prostatic Neoplasms
Janssen Research & Development, LLC 136
Not applicableStudy completedNCT03243604
What this trial is testing

CARdiotoxicity Profile of aBIraTeRone in prostAte Cancer : a pharmacoviGilancE Study

Who this might be right for
Arrhythmias, CardiacAtrial Fibrillation and FlutterTachycardia, Supraventricular+1 more
Groupe Hospitalier Pitie-Salpetriere 1,717
Large-scale testing (Phase 3)Active Not RecruitingNCT01957436
What this trial is testing

A Phase III Study for Patients With Metastatic Hormone-naïve Prostate Cancer

Who this might be right for
Metastatic Prostate Cancer
UNICANCER 1,173
Testing effectiveness (Phase 2)Ended earlyNCT03649841
What this trial is testing

Antiandrogen Therapy, Abiraterone Acetate, and Prednisone With or Without Neutron Radiation Therapy in Treating Patients With Prostate Cancer

Who this might be right for
Castration-Sensitive Prostate CarcinomaMetastatic Malignant Neoplasm in the BoneMetastatic Prostate Carcinoma+5 more
University of Washington 10
Testing effectiveness (Phase 2)Ended earlyNCT03360721
What this trial is testing

Apalutamide, Abiraterone Acetate, and Prednisone in Treating Participants With Metastatic Castration Resistant Prostate Cancer

Who this might be right for
Castration-Resistant Prostate CarcinomaProstate Adenocarcinoma Without Neuroendocrine DifferentiationStage IV Prostate Cancer AJCC v8+2 more
M.D. Anderson Cancer Center 7
Testing effectiveness (Phase 2)Study completedNCT00473512
What this trial is testing

A Safety and Efficacy Study of Abiraterone Acetate in Participants With Prostate Cancer Who Have Failed Hormone Therapy

Who this might be right for
Prostatic Neoplasms
Cougar Biotechnology, Inc. 54
Testing effectiveness (Phase 2)Ended earlyNCT01994590
What this trial is testing

Dovitinib (TKI258) and Abiraterone Acetate in Metastatic Castrate-Resistant Prostate Cancer (mCRPC)

Who this might be right for
Prostate Cancer
M.D. Anderson Cancer Center 4
Next Page